Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Rony Weitzen"'
Autor:
Chen Mayer, Maya Zilker, Nora Balint-Lahat, Rony Weitzen, Aviv Barzilai, Iris Barshack, Jonathan Weidenfeld
Publikováno v:
Human Pathology: Case Reports, Vol 23, Iss , Pp 200482- (2021)
Background: Metaplastic carcinoma of the breast is a general definition referring to a heterogeneous group of neoplasms characterized by a mixture of adenocarcinoma with areas of spindled, squamous or mesenchymal differentiation. Metaplastic breast c
Externí odkaz:
https://doaj.org/article/eb671f50535f491c9250b735d94047af
Autor:
Nancy Gavert, Yaara Zwang, Roi Weiser, Orli Greenberg, Sharon Halperin, Oded Jacobi, Giuseppe Mallel, Oded Sandler, Adi Jacob Berger, Erez Stossel, Daniil Rotin, Albert Grinshpun, Iris Kamer, Jair Bar, Guy Pines, Daniel Saidian, Ilan Bar, Shay Golan, Eli Rosenbaum, Andrei Nadu, Eytan Ben-Ami, Rony Weitzen, Hovav Nechushtan, Talia Golan, Baruch Brenner, Aviram Nissan, Ofer Margalit, Dov Hershkovitz, Guy Lahat, Ravid Straussman
Publikováno v:
Nature Cancer. 3:219-231
Translating preclinical studies to effective treatment protocols and identifying specific therapeutic responses in individuals with cancer is challenging. This may arise due to the complex genetic makeup of tumor cells and the impact of their multifa
Autor:
Noah Samuels MD, Yakov Freed MD, Rony Weitzen MD, Merav Ben-David MD, Yair Maimon PhD, Uri Eliyahu PhD, Raanan Berger MD, PhD
Publikováno v:
Integrative Cancer Therapies, Vol 17 (2018)
Background: Homeopathy has the potential to reduce symptoms related to cancer treatment. The present study examined the feasibility of a homeopathic consultation and treatment program, provided as part of an integrative oncology service. Methods: The
Externí odkaz:
https://doaj.org/article/6f42a8eff2284161b2dd0aa766fb6b6b
Publikováno v:
Nutrition and Cancer. 74:1338-1346
Castration-resistant prostate cancer (CRPC) is a devastating and incurable disease. Combined therapy using conventional anticancer drugs and a proprietary medical nutriment, fermented wheat germ extract (FWGE), also known as Avemar, has been suggeste
Autor:
Rony Weitzen, Orly Ohana, Iris Barshack, Eyal Klang, Orit Shimon, Marianne M. Amitai, Shelly Soffer, Noa Rozendorn
Publikováno v:
Clinical imaging. 56
Purpose Ki-67 is a marker of cellular proliferation that is commonly used for the assessment of rhabdomyosarcoma. The aim of this study was to investigate the associations between Ki-67 expression and primary tumor diameter with CT evidence of lymph
Autor:
Alona Zer, Oded Icht, Lilach Joseph, Dana Avram, Oded Jacobi, Eyal Fenig, Noga Kurman, Idit Peretz, Sivan Shamai, Ofer Merimsky, Eitan Ben-Ami, Roni Shapira, Anna Ewa Schwarzbach, Hanna Bernstine, Rony Weitzen, Olga Vornicova, Gil Bar-Sela, Salomon M. Stemmer, Michal Lotem
Publikováno v:
Journal of Clinical Oncology. 38:11518-11518
11518 Background: CKS is a mesenchymal neoplasm associated with HHV8 infection. Though recombinant INFa is approved for treatment of AIDS-related KS, data is limited regarding the role of immune modulation in CKS therapy. Based on favorable responses
Autor:
Salomon M. Stemmer, Eyal Fenig, O. Vornikova, Alona Zer, Hanna Bernstine, Sivan Shamai, Eytan Ben-Ami, Ronnie Shapira, Oded Jacobi, Ofer Merimsky, Gil Bar-Sela, Oded Icht, Michal Lotem, Rony Weitzen
Publikováno v:
Annals of Oncology. 30:ix135
Background CKS is an angioproliferative mesenchymal neoplasm causatively associated with human herpes virus 8 infection. Though recombinant IFNa is approved for treatment of AIDS-related KS, data is limited regarding the role of immune modulation. Ba
Autor:
Rony Weitzen, Shlomit Mesilaty-Gross, Israel Weiss, Yael Olswang-Kuz, Efrat Kessler, Boaz Liberman, Iris Vered, Eyal Ramu, Yair Anikster, Galia Gat-Yablonski
Publikováno v:
Clinica Chimica Acta. 412:1762-1766
Background Procollagen C-proteinase enhancer 1 (PCPE1), a glycoprotein secreted from differentiating osteoblast, enhances the rate-limiting step of collagen type I fibrillar formation. It is expressed and secreted by cells that produce collagen type
Autor:
Dana, Livne-Segev, Maya, Gottfried, Natalie, Maimon, Avivit, Peer, Avivit, Neumann, Henry, Hayat, Svetlana, Kovel, Avishay, Sella, Wilmosh, Mermershtain, Keren, Rouvinov, Ben, Boursi, Rony, Weitzen, Raanan, Berger, Daniel, Keizman
Publikováno v:
The Israel Medical Association journal : IMAJ. 16(6)
The VEGFR/PDGFR inhibitor sunitinib was approved in Israel in 2008 for the treatment of metastatic renal cell carcinoma (mRCC), based on an international trial. However, the efficacy of sunitinib treatment in Israeli mRCC patients has not been previo
Autor:
Michael A. Carducci, Maya Ish-Shalom, Rony Weitzen, Roberto Pili, Daniel Keizman, Natalie Maimon, Maya Gottfried, Avivit Neumann, Hans J. Hammers, Avivit Peer, Ben Boursi, Wilmosh Mermershtain, Henry Hayat, Mario A. Eisenberger, Victoria J. Sinibaldi, Keren Rouvinov, Raanan Berger, Avishay Sella, Svetlana Kovel
Publikováno v:
The oncologist. 19(1)
Obesity, smoking, hypertension, and diabetes are risk factors for renal cell carcinoma development. Their presence has been associated with a worse outcome in various cancers. We sought to determine their association with outcome of sunitinib treatme